Cargando…
Targeted Fisetin-Encapsulated β-Cyclodextrin Nanosponges for Breast Cancer
Fisetin (FS) is considered a safer phytomedicine alternative to conventional chemotherapeutics for breast cancer treatment. Despite its surpassing therapeutic potential, its clinical utility is hampered by its low systemic bioavailability. Accordingly, as far as we are aware, this is the first study...
Autores principales: | Aboushanab, Alaa R., El-Moslemany, Riham M., El-Kamel, Amal H., Mehanna, Radwa A., Bakr, Basant A., Ashour, Asmaa A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223291/ https://www.ncbi.nlm.nih.gov/pubmed/37242722 http://dx.doi.org/10.3390/pharmaceutics15051480 |
Ejemplares similares
-
History of Cyclodextrin Nanosponges
por: Krabicová, Ilona, et al.
Publicado: (2020) -
Chitosan-coated bovine serum albumin nanoparticles for topical tetrandrine delivery in glaucoma: in vitro and in vivo assessment
por: Radwan, Salma El-Sayed, et al.
Publicado: (2022) -
Tanshinone IIA loaded bioactive nanoemulsion for alleviation of lipopolysaccharide induced acute lung injury via inhibition of endothelial glycocalyx shedding
por: El-Moslemany, Riham M., et al.
Publicado: (2022) -
Evaluation and Characterization of Curcumin-β-Cyclodextrin and Cyclodextrin-Based Nanosponge Inclusion Complexation
por: Mashaqbeh, Hadeia, et al.
Publicado: (2021) -
Luteolin-loaded exosomes derived from bone marrow mesenchymal stem cells: a promising therapy for liver fibrosis
por: Ashour, Asmaa A., et al.
Publicado: (2022)